Patents by Inventor Carol Deby

Carol Deby has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition for the treatment and/or the prevention of atherosclerosis from infectious origin
    Publication number: 20060252707
    Abstract: The present invention is related to a pharmaceutical composition suitable for the treatment and/or the prevention of atherosclerosis from infectious origin, which comprises an adequate pharmaceutical carrier, a corticosteroid and a stilbene-type alexin, preferably further comprising a flavonoid to regenerate the stilbene and/or to increase the effect of the latter. The latter compositions are highly suitable for long-term therapies like the treatment of atherosclerosis from infectious origin.
    Type: Application
    Filed: May 28, 2004
    Publication date: November 9, 2006
    Applicant: UNIVERSITE DE LIEGE
    Inventors: Carol Deby, Ginette Dupont, Didier Serteyn
  • Human myeloperoxidase and its therapeutic application
    Patent number: 5985272
    Abstract: Human myeloperoxidase produced by culturing prokaryotic or eukaryotic cells transformed by a vector for the expression of human myeloperoxidase in said cells.
    Type: Grant
    Filed: December 31, 1996
    Date of Patent: November 16, 1999
    Assignee: Universite Libre De Bruxelles
    Inventors: Carol Deby, Joel Pincemail, Alex Bollen
  • Human myeloperoxidase and its therapeutic application
    Patent number: 5846799
    Abstract: A method of preparing biologically active human myeloperoxidase including the steps of preparing a vector for the expression of human myeloperoxidase. The vector includes plasmid pNIV2703. The plasmid includes a HindIII-SnaBI, HindIII-EcoRV or HindIII-HpaI cassette, the cassette including a complete DNA sequence for hMPO as shown in FIG. 1. CHO cells are transformed with the vector. The cells are cultured. The biologically active human myeloperoxidase is recovered.
    Type: Grant
    Filed: August 20, 1993
    Date of Patent: December 8, 1998
    Assignee: La Region Wallone
    Inventors: Carol Deby, Joel Pincemail, Alex Bollen
  • Human myeloperoxidase and its therapeutic application
    Patent number: 5460961
    Abstract: A substantially pure recombinant human myeloperoxidase heme-containing precursor, comprising a glycoprotein of 84 KD with the amino acid sequence coded for by the nucleotide sequence from 145 to 2235 corresponding to codons 49 to 745 in phase after the first methionine codon in FIG. 1 produced by culturing prokaryotic or eukaryotic cells transformed by a vector for the expression of human myeloperoxidase precursor in said cells.
    Type: Grant
    Filed: January 16, 1991
    Date of Patent: October 24, 1995
    Assignee: La Region Wallonne
    Inventors: Carol Deby, Joel Pincemail, Alex Bollen